Edward J. Ludwig - 04 May 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Director
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
04 May 2023
Net transactions value
$0
Form type
4
Filing time
05 May 2023, 16:27:13 UTC
Previous filing
21 Nov 2022
Next filing
19 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Deferred Stock Units Award $0 +3,946 +11% $0.000000 41,382 04 May 2023 Common Stock 3,946 Direct F1, F2, F3
transaction BSX Deferred Stock Units Award $0 +2,984 +7.2% $0.000000 44,366 04 May 2023 Common Stock 2,984 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Reflects a value of $205,000 divided by the closing price of common stock on the date of grant.
F3 Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
F4 Reflects a value of $155,000 divided by the closing price of common stock on the date of grant.
F5 Deferred stock units were granted in lieu of quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.